{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-021113","form_type":"8-K","ticker":"ENSC","cik":"0001716947","company_name":"Ensysce Biosciences, Inc.","filed_at":"2023-06-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.197136+00:00","generated_at":"2026-06-14T01:21:54.904552+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Ensysce Biosciences regains compliance with Nasdaq equity requirement on June 13","bullets":["Received formal notice from Nasdaq that it now meets the equity requirement under Listing Rule 5550(b)(1).","The Nasdaq Hearings Panel matter concerning listing compliance has been closed.","Ensysce common stock (ENSC) will continue trading on the Nasdaq Capital Market.","Company cautioned that future compliance with all Nasdaq requirements is not guaranteed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-021113","json":"https://secwatch.observer/filing/0001493152-23-021113.json","markdown":"https://secwatch.observer/filing/0001493152-23-021113.md","text":"https://secwatch.observer/filing/0001493152-23-021113.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716947/000149315223021113/0001493152-23-021113-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716947/000149315223021113/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T01:21:54.904552+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}